Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020.

ABSTRACT:

Background

External quality assessments (EQAs) for the molecular detection of human respiratory syncytial virus (RSV) are necessary to ensure the standardisation of reliable results. The Phase II, 2019-2020 World Health Organization (WHO) RSV EQA included 28 laboratories in 26 countries. The EQA panel evaluated performance in the molecular detection and subtyping of RSV-A and RSV-B. This manuscript describes the preparation, distribution, and analysis of the 2019-2020 WHO RSV EQA.

Methods

Panel isolates underwent whole genome sequencing and in silico primer matching. The final panel included nine contemporary, one historical virus and two negative controls. The EQA panel was manufactured and distributed by the UK National External Quality Assessment Service (UK NEQAS). Natio

SUBMITTER: Williams T 

PROVIDER: S-EPMC9849090 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature